Stephen Lockhart | Director, Senior Consultant
HURST GRANGE ASSOCIATES

Stephen Lockhart, Director, Senior Consultant, HURST GRANGE ASSOCIATES

I qualified in Medicine from the University of Oxford in 1980.  After working around the UK in hospital medicine and research, I joined the pharmaceutical industry in 1986.  I am a Fellow of the Faculty of Pharmaceutical Medicine and a Fellow of the Academy of Medical Sciences. For over 30 years I have been engaged in global vaccine clinical R&D across all phases, in Lederle, Wyeth, Emergent BioSolutions, sanofi-pasteur MSD, and most recently Pfizer.  I was involved with bringing some major vaccines to the clinic, including the first pneumococcal and the first meningococcal conjugate vaccines and the first modRNA COVID-19 vaccine, but have also learnt much from less successful developments. I am currently a consultant with Hurst Grange Associates, stephenlockhart@hurstgrangeassociates.co.uk.

Appearances:



Day 2 - Wednesday 30th October @ 15:40

The Role of Vaccines & mAbs in Neonatal Sepsis Prevention

last published: 03/Oct/24 13:35 GMT

back to speakers